Cargando…
Fetal goiter identified in a pregnant woman with triiodothyronine-predominant graves’ disease: a case report
BACKGROUND: Approximately 10% of all Graves’ disease cases are triiodothyronine (T3)-predominant. T3-predominance is characterized by higher T3 levels than thyroxine (T4) levels. Thyroid stimulating hormone receptor autoantibody (TRAb) levels are higher in T3-predominant Graves’ disease cases than i...
Autores principales: | Fujishima, Akiko, Sato, Akira, Miura, Hiroshi, Shimoda, Yuki, Kameyama, Saeko, Ariake, Chika, Adachi, Hiroyuki, Fukuoka, Yuki, Terada, Yukihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268772/ https://www.ncbi.nlm.nih.gov/pubmed/32493403 http://dx.doi.org/10.1186/s12884-020-03035-2 |
Ejemplares similares
-
Current knowledge about the in utero and peripartum management of fetal goiter associated with maternal Graves’ disease
por: Iijima, Shigeo
Publicado: (2019) -
Prenatal management of fetal goiter alternating between hypothyroidism and hyperthyroidism in a mother with Graves’ disease
por: Didier‐Mathon, Hortense, et al.
Publicado: (2021) -
Two cases of fetal goiter
por: Saini, Ashish, et al.
Publicado: (2012) -
Chylothorax Associated with Substernal Goiter in Graves’ Disease Treated with Radioactive Iodine
por: Young Oh, Seo, et al.
Publicado: (2017) -
Intra-amniotic thyroxine to treat fetal goiter
por: Kim, Min-Jung, et al.
Publicado: (2016)